Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors

Abstract The widespread use of nanomaterials (NMs) has raised concerns that exposure to them may introduce potential risks to the human body and environment. The liver is the main target organ for NMs. Hepatotoxic effects caused by NMs have been observed in recent studies but have not been linked to...

Full description

Bibliographic Details
Main Authors: Ting Sun, Yiyuan Kang, Jia Liu, Yanli Zhang, Lingling Ou, Xiangning Liu, Renfa Lai, Longquan Shao
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-021-00843-2
_version_ 1818473384750612480
author Ting Sun
Yiyuan Kang
Jia Liu
Yanli Zhang
Lingling Ou
Xiangning Liu
Renfa Lai
Longquan Shao
author_facet Ting Sun
Yiyuan Kang
Jia Liu
Yanli Zhang
Lingling Ou
Xiangning Liu
Renfa Lai
Longquan Shao
author_sort Ting Sun
collection DOAJ
description Abstract The widespread use of nanomaterials (NMs) has raised concerns that exposure to them may introduce potential risks to the human body and environment. The liver is the main target organ for NMs. Hepatotoxic effects caused by NMs have been observed in recent studies but have not been linked to liver disease, and the intrinsic mechanisms are poorly elucidated. Additionally, NMs exhibit varied toxicokinetics and induce enhanced toxic effects in susceptible livers; however, thus far, this issue has not been thoroughly reviewed. This review provides an overview of the toxicokinetics of NMs. We highlight the possibility that NMs induce hepatic diseases, including nonalcoholic steatohepatitis (NASH), fibrosis, liver cancer, and metabolic disorders, and explore the underlying intrinsic mechanisms. Additionally, NM toxicokinetics and the potential induced risks in the livers of susceptible individuals, including subjects with liver disease, obese individuals, aging individuals and individuals of both sexes, are summarized. To understand how NM type affect their toxicity, the influences of the physicochemical and morphological (PCM) properties of NMs on their toxicokinetics and toxicity are also explored. This review provides guidance for further toxicological studies on NMs and will be important for the further development of NMs for applications in various fields.
first_indexed 2024-04-14T04:23:12Z
format Article
id doaj.art-b4e3037403e84433a72cf314a3b4bbc8
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-14T04:23:12Z
publishDate 2021-04-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-b4e3037403e84433a72cf314a3b4bbc82022-12-22T02:12:26ZengBMCJournal of Nanobiotechnology1477-31552021-04-0119112310.1186/s12951-021-00843-2Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factorsTing Sun0Yiyuan Kang1Jia Liu2Yanli Zhang3Lingling Ou4Xiangning Liu5Renfa Lai6Longquan Shao7Foshan Stomatological Hospital, Foshan UniversityStomatological Hospital, Southern Medical UniversityStomatological Hospital, Southern Medical UniversityStomatological Hospital, Southern Medical UniversityMedical Center of Stomatology, The First Affiliated HospitalMedical Center of Stomatology, The First Affiliated HospitalMedical Center of Stomatology, The First Affiliated HospitalStomatological Hospital, Southern Medical UniversityAbstract The widespread use of nanomaterials (NMs) has raised concerns that exposure to them may introduce potential risks to the human body and environment. The liver is the main target organ for NMs. Hepatotoxic effects caused by NMs have been observed in recent studies but have not been linked to liver disease, and the intrinsic mechanisms are poorly elucidated. Additionally, NMs exhibit varied toxicokinetics and induce enhanced toxic effects in susceptible livers; however, thus far, this issue has not been thoroughly reviewed. This review provides an overview of the toxicokinetics of NMs. We highlight the possibility that NMs induce hepatic diseases, including nonalcoholic steatohepatitis (NASH), fibrosis, liver cancer, and metabolic disorders, and explore the underlying intrinsic mechanisms. Additionally, NM toxicokinetics and the potential induced risks in the livers of susceptible individuals, including subjects with liver disease, obese individuals, aging individuals and individuals of both sexes, are summarized. To understand how NM type affect their toxicity, the influences of the physicochemical and morphological (PCM) properties of NMs on their toxicokinetics and toxicity are also explored. This review provides guidance for further toxicological studies on NMs and will be important for the further development of NMs for applications in various fields.https://doi.org/10.1186/s12951-021-00843-2NanomaterialsHepatic diseaseMechanismsSusceptible individualsToxicokinetics
spellingShingle Ting Sun
Yiyuan Kang
Jia Liu
Yanli Zhang
Lingling Ou
Xiangning Liu
Renfa Lai
Longquan Shao
Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
Journal of Nanobiotechnology
Nanomaterials
Hepatic disease
Mechanisms
Susceptible individuals
Toxicokinetics
title Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
title_full Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
title_fullStr Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
title_full_unstemmed Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
title_short Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
title_sort nanomaterials and hepatic disease toxicokinetics disease types intrinsic mechanisms liver susceptibility and influencing factors
topic Nanomaterials
Hepatic disease
Mechanisms
Susceptible individuals
Toxicokinetics
url https://doi.org/10.1186/s12951-021-00843-2
work_keys_str_mv AT tingsun nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT yiyuankang nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT jialiu nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT yanlizhang nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT linglingou nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT xiangningliu nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT renfalai nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors
AT longquanshao nanomaterialsandhepaticdiseasetoxicokineticsdiseasetypesintrinsicmechanismsliversusceptibilityandinfluencingfactors